Literature DB >> 3817810

Genetic and clinical studies on 19 families with adenine phosphoribosyltransferase deficiencies.

N Kamatani, C Terai, S Kuroshima, K Nishioka, K Mikanagi.   

Abstract

Adenine phosphoribosyltransferase (APRT) deficiency leading to 2,8-dihydroxyadenine (DHA) urolithiasis has been considered a rare cause of urolithiasis and renal insufficiency. We have examined samples from 19 Japanese families with DHA lithiasis. In 79% of the families, patients only partially lacked hemolysate APRT activities, clearly contrasting with the complete deficiency in all the patients from non-Japanese families so far reported. All patients with DHA lithiasis were homozygotes for defective APRT genes, whether the deficiency was complete or partial. In family studies we found two symptomatic and four asymptomatic homozygous family members. The segregation figures are compatible with the hypothesis of a simple autosomal recessive mode of inheritance. By analyzing the data stored by a large clinical laboratory in Japan, we estimated that 0.00368% of the general population has DHA lithiasis. These data indicate that more than 1% of the general population possess mutant alleles of the APRT gene as heterozygotes. Our present studies indicate that most of the patients with this disease are undiagnosed in Japan, and probably in other countries also.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3817810     DOI: 10.1007/bf00591080

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  18 in total

1.  Adenine phosphoribosyltransferase deficiency in man. Report of a second family.

Authors:  I H Fox; J C Meade; W N Kelley
Journal:  Am J Med       Date:  1973-11       Impact factor: 4.965

2.  [Epidemiology of urolithiasis in Japan (author's transl)].

Authors:  O Yoshida
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1979-09

3.  A rare enzyme deficiency causing formation of 2,8-dihydroxyadenine (purine body) calculi.

Authors:  P Szönyi; M Berényi; J Tóth
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

4.  Urolithiasis due to 2,8-dihydroxyadenine in an adult.

Authors:  M H Gault; H A Simmonds; W Snedden; D Dow; D N Churchill; H Penney
Journal:  N Engl J Med       Date:  1981-12-24       Impact factor: 91.245

5.  [A case of right ureteral stone with complete deficiency of adenine phosphoribosyltransferase].

Authors:  T Ito; T Sugimoto; M Maekawa; A Horii; R Yasumoto
Journal:  Hinyokika Kiyo       Date:  1985-08

6.  Altered kinetic properties of a mutant adenine phosphoribosyltransferase.

Authors:  S Fujimori; I Akaoka; F Takeuchi; H Kanayama; K Tatara; K Nishioka; N Kamatani
Journal:  Metabolism       Date:  1986-02       Impact factor: 8.694

7.  2,8-dihydroxyadenine urolithiasis: review of the literature and report of a case in the United States.

Authors:  F R Witten; J W Morgan; J G Foster; J F Glenn
Journal:  J Urol       Date:  1983-11       Impact factor: 7.450

8.  Severe impairment in adenine metabolism with a partial deficiency of adenine phosphoribosyltransferase.

Authors:  N Kamatani; F Takeuchi; Y Nishida; H Yamanaka; K Nishioka; K Tatara; S Fujimori; K Kaneko; I Akaoka; Y Tofuku
Journal:  Metabolism       Date:  1985-02       Impact factor: 8.694

9.  Common characteristics of mutant adenine phosphoribosyltransferases from four separate Japanese families with 2,8-dihydroxyadenine urolithiasis associated with partial enzyme deficiencies.

Authors:  S Fujimori; I Akaoka; K Sakamoto; H Yamanaka; K Nishioka; N Kamatani
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

10.  Establishment and characterization of B cell lines from individuals with various types of adenine phosphoribosyltransferase deficiencies.

Authors:  T Nobori; N Kamatani; K Mikanagi; Y Nishida; K Nishioka
Journal:  Biochem Biophys Res Commun       Date:  1986-06-30       Impact factor: 3.575

View more
  31 in total

1.  Obstructive uropathy and severe acute kidney injury from renal calculi due to adenine phosphoribosyltransferase deficiency.

Authors:  Siew Le Chong; Yong Hong Ng
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

2.  Identification of a common nonsense mutation in Japanese patients with type I adenine phosphoribosyltransferase deficiency.

Authors:  A Sahota; J Chen; K Asaki; H Takeuchi; P J Stambrook; J A Tischfield
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

3.  Use of LightCycler mutation analysis to detect type II adenine phosphoribosyltransferase deficiency in two patients with 2,8-dihydroxyadeninuria.

Authors:  Hirokazu Ikeda; Tuneki Watanabe; Daiske Toyama; Keiichi Isoyama
Journal:  CEN Case Rep       Date:  2015-05-26

4.  Adenine phosphoribosyltransferase deficiency in children.

Authors:  Jérôme Harambat; Guillaume Bollée; Michel Daudon; Irène Ceballos-Picot; Albert Bensman
Journal:  Pediatr Nephrol       Date:  2012-01-03       Impact factor: 3.714

5.  Early Recognition and Management of Rare Kidney Stone Disorders.

Authors:  Boss Goldstein; David S Goldfarb
Journal:  Urol Nurs       Date:  2017 Mar-Apr

6.  Identification of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APART*Q0) leading to 2,8-dihydroxyadenine urolithiasis.

Authors:  N Kamatani; S Kuroshima; H Yamanaka; S Nakashe; H Take; M Hakoda
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

7.  Selection of human cells having two different types of mutations in individual cells (genetic/artificial mutants). Application to the diagnosis of the heterozygous state for a type of adenine phosphoribosyltransferase deficiency.

Authors:  N Kamatani; S Kuroshima; C Terai; K Kawai; K Mikanagi; K Nishioka
Journal:  Hum Genet       Date:  1987-06       Impact factor: 4.132

8.  Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis.

Authors:  S J Engle; M G Stockelman; J Chen; G Boivin; M N Yum; P M Davies; M Y Ying; A Sahota; H A Simmonds; P J Stambrook; J A Tischfield
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

9.  Only three mutations account for almost all defective alleles causing adenine phosphoribosyltransferase deficiency in Japanese patients.

Authors:  N Kamatani; M Hakoda; S Otsuka; H Yoshikawa; S Kashiwazaki
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

10.  Human adenine phosphoribosyltransferase. Identification of allelic mutations at the nucleotide level as a cause of complete deficiency of the enzyme.

Authors:  Y Hidaka; T D Palella; T E O'Toole; S A Tarlé; W N Kelley
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.